Opendata, web and dolomites

LongActNow SIGNED

Long Acting Medicines for Complex Therapeutics Needed Now

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LongActNow project word cloud

Explore the words cloud of the LongActNow project. It provides you a very rough idea of what is the project "LongActNow" about.

university    auml    business    technologies    technische    janssen    stage    commercial    creativity    ul    industrial    entrepreneurship    mindset    ingredients    doctorate    efficient    applicable    formulation    switching    changer    crystal    phd    innovative    fusing    of    manipulation    ways    engineers    tud    physical    centres    suspensions    meet    prediction    expertise    pharmaceutica    pharmaceutical    platform    apis    innovation    medicines    linked    limerick    crystallisation    international    academic    skilled    comfortable    oriented    leveraged    acting    domain    active    trinity    injectable    la    manufacturing    trained    solution    benefits    formulations    stimulate    viability    optimise    dortmund    limited    stability    game    solvent    scientists    removal    tcd    capability    optimization    esrs    pharma    eid    portfolio    platforms    demand    drug    api    longactnow    pharmacokinetics    universit    impacting    patients    dublin    pharmacological    unlock    skills    college    nourish   

Project "LongActNow" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITY OF LIMERICK 

Organization address
address: NATIONAL TECHNOLOGICAL PARK, PLASSEY
city: LIMERICK
postcode: -
website: www.ul.ie

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Total cost 1˙292˙901 €
 EC max contribution 1˙292˙901 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2019
 Funding Scheme MSCA-ITN-EID
 Starting year 2019
 Duration (year-month-day) from 2019-10-01   to  2023-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITY OF LIMERICK IE (LIMERICK) coordinator 274˙684.00
2    JANSSEN PHARMACEUTICA NV BE (BEERSE) participant 512˙640.00
3    TECHNISCHE UNIVERSITAT DORTMUND DE (DORTMUND) participant 505˙576.00

Map

 Project objective

LongActNow will design a novel platform technology for the development of long acting (LA) suspensions of complex active pharmaceutical ingredients (API), involving innovative manipulation of API crystal formation and growth and solvent removal. LA formulations have become a game-changer in terms of bringing existing and new API in more cost-efficient and comfortable ways to patients, often directly impacting commercial viability of new products. However, existing technology platforms are only applicable to a limited part of the pharma portfolio and do not allow to fully unlock all benefits linked to LA. LongActNow is a unique European Industrial Doctorate (EID) initiative that aims to meet the current and future demand for highly skilled scientists and engineers in pharmaceutical development and manufacturing of LA formulations. The initiative is leveraged by fusing the capabilities of four significant international academic and industrial centres (University of Limerick (UL), Trinity College Dublin (TCD), Technische Universität Dortmund (TUD) and Janssen Pharmaceutica (Janssen)) with specific expertise in crystallisation, solution behaviour, modelling, solvent switching, pharmacokinetics and formulation. LongActNow will advance European research in the field of crystallisation technologies, more specifically the design, development and optimization of prediction and production technologies to produce medicines with well controlled physical and pharmacological properties. The project will produce five Early Stage Researchers (ESRs) trained in crystallisation and formulation to a PhD level with a unique capability to optimise the stability and duration of activity of injectable suspensions for complex APIs and will nourish the creativity, entrepreneurship, management and business skills of ESRs in the domain of drug development and manufacturing, to stimulate an innovation-oriented mindset in future pharmaceutical researchers.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LONGACTNOW" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LONGACTNOW" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

EAGRE (2020)

Eagre/Aegir: high-seas wave-impact modelling

Read More  

SuperCol (2020)

SuperCol: Rational design of super-selective and responsive colloidal particles for biomedical applications

Read More  

ApPEARS (2019)

Appearance Printing - European Advanced Research School

Read More